Newborn Screening For Genetic Disorders Is An Important Trend In The Next Generation Sequencing Market

EINPRESSWIRE Press Release
Next Generation Sequencing Market – Opportunities And Strategies Forecast To 2030

Next Generation Sequencing Market – Opportunities And Strategies Forecast To 2030

The Business Research Company’s Next Generation Sequencing Market – Opportunities And Strategies – Global Next Generation Sequencing Market Forecast To 2030

LONDON, GREATER LONDON, UK, March 23, 2021 /EINPresswire.com/ — Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports

Next generation sequencing is being used to carry out newborn screening. Newborn screening (NBS) is an important public health program aimed at improving children’s health and is widely used in several countries across the world. Newborn babies are screened for several disorders using dried blood spots (DBS) taken shortly after the birth of the babies. Next generation sequencing is being used to test for several disorders and genetic disorders, such as congenital hypothyroidism (CH), phenylketonuria (PKU), congenital adrenal hyperplasia (CAH), cystic fibrosis (CF), and hemoglobinopathy disorders in newborns. This early diagnosis helps in improving the negative sequelae associated with a subset of genetic disorders, and thus is a trend in the next-generation sequencing (NGS) market. Next-generation sequencing is gaining traction in the field of genetic diagnosis as it can sequence millions of DNA molecules simultaneously.

Major players in the next generation sequencing market are Illumina Inc., Thermo Fisher Scientific Inc., BGI Group, Agilent Technologies Inc., Qiagen N.V., Hoffmann-La Roche AG, Eurofins Scientific, Oxford Nanopore Technologies, Pacific Biosciences, and 10x Genomics.

Read More On The Global Next Generation Sequencing Market Report: https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market

The global next-generation sequencing market size is expected to grow from $7.05 billion in 2020 to $9.04 billion in 2021 at a compound annual growth rate (CAGR) of 28.2%. Next generation sequencing market growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The next generation sequencing market is expected to reach $23.15 billion in 2025 at a CAGR of 27%. The countries with next generation sequencing market shares covered in TBRC’s report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global next generation sequencing market is segmented by product into NextSeq Systems, MiniSeq Systems, NovaSeq Systems, iSeq 100 Systems, Ion PGM Systems, Ion Proton Systems, Ion GeneStudio S5 Systems, PacBio RS II Systems, Sequel Systems, others, by technology into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, other sequencing technologies, and by application into diagnostics, drug discovery, other applications.

Next Generation Sequencing Market – Opportunities And Strategies – Global Next Generation Sequencing Market Forecast To 2030 is one of a series of new reports from The Business Research Company that provides next-generation sequencing market overview, forecast next-generation sequencing market size and growth for the whole market, next-generation sequencing market segments, and geographies, next-generation sequencing market trends, next-generation sequencing market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Next Generation Sequencing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3294&type=smp

Here Is A List Of Similar Reports By The Business Research Company:
Sequencing Market – By Type (Next Generation Sequencing, Third Generation Sequencing And Sanger Sequencing), By Products (Consumables, Software, Sequencing Services And Instruments), And By Region, Opportunities And Strategies – Global Forecast To 2023
https://www.thebusinessresearchcompany.com/report/sequencing-market

Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth And Change To 2030
https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report-2020-30-covid-19-growth-and-change

PCR And Realtime PCR Testing Global Market Report 2021: COVID-19 Implications And Growth To 2030
https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-and-real-time-polymerase-chain-reaction-pcr-testing-market-global-report-2020-2030-covid-19-implications-and-growth

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology. TBRC excels in company, market, and consumer research.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn